Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Wednesday, November 13, 2024, at 2 p.m. CET / 8 a.m. ET ...

China Has Detained Senior AstraZeneca Executive A senior AstraZeneca executive is under detention by Chinese authorities investigating the U.K. pharmaceutical company's employees in the country. Leon ...

Current health news highlights the expected high demand for Novo Nordisk's obesity drug in India, the need for personalized approaches in knee replacement surgeries, Gilead's notable financial ...

The Financial Times features significant stories in finance and business. AstraZeneca's China chief has been detained amid investigations, the UK regulator drops a probe into Unilever's "green" claims ...

Toyota’s July-September profit sank to less than half of what it was in the same period the previous year, as a production stoppage that followed a certification scandal and recalls dented vehicle ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

Health-care companies ticked up amid mixed earnings and consolidation prospects. ADRs of Danish drug giant Novo Nordisk fell after sales of its blockbuster Wegovy weight-loss drug failed to surpass ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Also in today’s newsletter, AstraZeneca’s top China executive detained by authorities, and German chancellor Olaf Scholz ...

Key Takeaways Zacks earnings estimates for AstraZeneca are currently at $4.06 per share. However, the earnings picture ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...